A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC

Clinical trial NCT04023617 · UNKNOWN

Trial details

NCT number: NCT04023617
Sponsor: Peking University Cancer Hospital & Institute
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Docetaxel Nivolumab

Start date: 2019-07-08
Primary completion: 2020-06-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.